Chemoproteomics Market Expansion Supported By Growing Demand For Personalized Medicine And Advances In Genomic Diagnostics
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Chemoproteomics Market Expected To Reach Based On Its 2026 Value?
The chemoproteomics market has experienced substantial growth in recent times. Its valuation is anticipated to climb from $1.77 billion in 2025 to $2.01 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 13.5%. This expansion during the preceding period is largely due to increased investment in proteomics research, expanding pharmaceutical R&D initiatives, the adoption of sophisticated mass spectrometry techniques, intensified endeavors in drug discovery and biomarker identification, and the proliferation of academic and research institutions.
The chemoproteomics market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $3.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.7%. Key factors contributing to this growth during the forecast period include the increasing integration of AI into proteomics analysis, a heightened demand for high-throughput chemoproteomics platforms, a stronger emphasis on personalized medicine, the expansion of contract research organizations, and the wider adoption of multi-omics approaches. Significant trends expected during the same period encompass the growing acceptance of activity-based protein profiling, a surge in demand for quantitative proteomics techniques, the increasing incorporation of structural proteomics approaches, the broadening of affinity-based protein profiling applications, and a greater emphasis on label-free and isotope labeling methods.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Primary Drivers Are Impacting The Chemoproteomics Market Growth?
The increasing need for personalized medicine is anticipated to drive the expansion of the chemoproteomics market in the future. Personalized medicine refers to healthcare interventions and treatments precisely adapted to individual patients, considering their genetic makeup, biomarkers, and unique disease characteristics. The escalation in demand for personalized medicine is attributed to breakthroughs in genomic technologies and molecular diagnostics, which enable physicians to tailor therapies specifically to a patient’s genetic profile, thereby improving outcomes. Chemoproteomics supports personalized medicine by identifying specific protein-drug interactions and biomarker profiles for each patient, allowing for customized therapies that maximize efficacy and minimize negative side effects. For example, in February 2024, information from the Personalized Medicine Coalition, a US-based non-profit organization, revealed that the Food and Drug Administration sanctioned 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. This total included seven cancer drugs and three for other diseases and conditions. Ultimately, the burgeoning demand for personalized medicine is propelling the growth of the chemoproteomics market.
How Is Segmentation Applied In The Chemoproteomics Market Segment Analysis?
The chemoproteomics market covered in this report is segmented –
1) By Technology: Activity Based Protein Profiling, Quantitative Proteomics, Structural Proteomics, Affinity Based Protein Profiling, Label Free And Isotope Labeling Techniques
2) By Product Type: Reagents And Kits, Instruments, Software, Services
3) By Application: Drug Discovery, Target Identification And Validation, Biomarker Discovery, Proteome Profiling, Other Application
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-User
Subsegments:
1) By Activity Based Protein Profiling: Enzyme Activity Profiling, Covalent Probe Profiling, Targeted Activity Profiling, Functional Protein Profiling
2) By Quantitative Proteomics: Stable Isotope Labeling, Isobaric Tag Labeling, Label Free Quantification, Metabolic Labeling
3) By Structural Proteomics: X Ray Crystallography, Nuclear Magnetic Resonance, Cryogenic Electron Microscopy, Hydrogen Deuterium Exchange
4) By Affinity Based Protein Profiling: Protein Ligand Interaction, Antibody Based Capture, Small Molecule Affinity Capture, Protein Complex Isolation
5) By Label Free and Isotope Labeling Techniques: Label Free Mass Spectrometry, Isotope Coded Affinity Tagging, Dimethyl Labeling, Tandem Mass Tag Labeling
Which Trends Are Influencing Demand In The Chemoproteomics Market?
Major companies operating in the chemoproteomics market are focusing on developing innovative solutions, such as live cell target engagement platforms, to accelerate drug discovery and improve early-stage efficacy prediction. A live cell target engagement platform is a technology designed to measure how drug candidates interact with their molecular targets inside living cells in real time, providing data that is more accurate and physiologically relevant than traditional in vitro assays. For instance, in September 2025, LeadArt Biotechnologies Inc., a US-based biotechnology research company, launched its INTRAP platform, a next-generation live-cell target engagement and chemoproteomics system, at AHeDD 2025. This platform integrates chemoproteomics, automation, and AI to analyze drug-target interactions directly within living cells. This capability enables researchers to identify and optimize drug candidates more efficiently, particularly for challenging or “undruggable” targets. By providing real-time, physiologically relevant data, INTRAP aims to improve early-stage success rates and accelerate the overall drug discovery process.
Who Are The Companies Participating In The Chemoproteomics Market Environment?
Major companies operating in the chemoproteomics market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies Inc., Shimadzu Corporation, PerkinElmer Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Evotec SE, Promega Corporation, Cell Signaling Technology Inc., Seer Inc., ChomiX Biotech Inc., Abcam plc, Creative Proteomics Inc., MtoZ Biolabs Inc., Allumiqs Corporation, Dalriada Drug Discovery Ltd., MS Bioworks LLC.
Get The Full Chemoproteomics Market Report:
https://www.thebusinessresearchcompany.com/report/chemoproteomics-market-report
Where Is The Chemoproteomics Market Most Concentrated Geographically?
North America was the largest region in the chemoproteomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemoproteomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Chemoproteomics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Chemoproteomics Market 2026, By The Business Research Company
adeno-associated virus (avv) vectors in gene therapy market report 2026
gastric cancer therapy market report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report
over the counter (otc) drugs market report 2026
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
